bladder cancer

Urology Product Preview November 2013Urology drugs and devices in the pipeline from AltheRx Pharmaceuticals, TARIS Biomedical, AstraZeneca, NxThera, NovaBay Pharmaceuticals, and OncoGenex Pharmaceuticals.
Study: RT viable alternative to cystectomyStandard and reduced high-dose volume radiation therapy for muscle-invasive bladder cancer provide similar tumor control and decreased late toxicity when compared to surgery, say the authors of a study from the United Kingdom.
October 2013 New Urology Products & ServicesThe latest products and services from Cook Medical, American Medical Systems, Dialog Medical, Astellas Pharma U.S., Giffen Solutions, the Société Internationale d’Urologie, Merck Consumer Care, and the Bladder Cancer Advocacy Network.
Urology Product PreviewDrugs and devices in the pipeline from Targacept, Inc., Cubist, OncoGenex Pharmaceuticals, Inc., Apricus Biosciences, and Nymox Pharmaceutical Corp.
‘Scent device’ may help detect bladder cancerBritish researchers have developed a device that they say is able to read odors in urine to help diagnose patients with early signs of bladder cancer.
Best of AUA 2013: Outcomes AnalysisDanil V. Makarov, MD, MHS, presents the take home messages on outcomes analysis.
Best of AUA 2013: Bladder CancerEdmund Chiong, MD, presents the take home messages on bladder cancer from the AUA annual meeting in San Diego.
Closer surveillance, treatment needed in bladder CaMore intense surveillance and treatment in the first 2 years after a bladder cancer diagnosis could reduce the number of patients whose cancer recurs and lower the death rate from this disease, according to researchers from UCLA’s Jonsson Comprehensive Cancer Center.
MicroRNAs may predict urothelial cancer progressionMicroRNA expression appears to serve as a biomarker for predicting the progression of bladder urothelial carcinoma, the authors of a study from Israel reported.
Bladder Ca: New findings on its course, metastasisTwo recent studies appear to shed light on the effect of smoking on bladder cancer outcomes and the role a certain protein plays in metastatic disease.